Cancer Research Center – Roanoke
CANCER RESEARCH CENTER – ROANOKE
About the Cancer Research Center – Roanoke
Cancer research is woven through the work of numerous laboratories at the Fralin Biomedical Research Institute. Investigators strive to understand the molecular mechanisms underlying the genetic and environmental factors that encourage cancer growth, as well as how cancer multiplies and migrates throughout the body. From childhood cancers to breast cancer to brain cancers, including the deadliest of all, glioblastoma, researchers at the institute are developing methods to make cancer cells more vulnerable to existing treatments and innovating completely new treatments to halt cancer and prevent its return.
The center is led by Jennifer Munson, Ph.D., whose research focuses on the role of interstitial fluid flow in tumor development.
Center Contacts
- Director: Jenny Munson, Ph.D
- Administrative Coordinator: Shelby Yancey
-
Home Item
Jenny Munson, Ph.D. , homeProfessor, Director, Cancer Research Center – Roanoke
-
Home Item
Finkielstein Lab , homeThe Finkielstein lab studies how disruption of the body's circadian rhythm influences cancer initiation and progression.
-
Home Item
Lamouille Lab , homeThe Lamouille Lab studies ways to deregulate cancer cell communication and is developing new therapeutic strategies to stall cancer stem cell proliferation and metastases.
-
Home Item
Lee Lab , homeThe Lee lab develops various types of biomaterials to enhance anti-tumor immune responses without toxic effects, and to understand their therapeutic mechanisms in a range of cancers.
-
Home Item
Munson Lab , homeThe Munson Lab studies the tumor microenvironment in cancers, including glioblastoma, the deadliest form of brain cancer. Our research focuses on the emerging research area of fluid flow.
-
Home Item
Sheng Lab , homeResearchers in the Sheng Laboratory are particularly interested in glioblastoma multiforme.
-
Home Item
Wu Lab , homeThe Advances in Technology and Drug Delivery Initiative Laboratory, led by Cheng-Chia "Fred" Wu, M.D., Ph.D., studies the translation of novel drug delivery technologies to treating children with brain tumors.
-
Article Item
-
Article Item
-
Article Item
Finding community and focus in interdisciplinary cancer research , article Date: Apr 11, 2025 -
-
Article ItemResearchers receive $2.17 million grant to study noninvasive treatment for traumatic brain injury symptoms , article
Funding from the National Institutes of Health will allow the team to investigate how a technique called cranial osteopathic manual manipulation might affect brain fluid motion and help balance the autonomic nervous system.
Date: Mar 14, 2025 - -
Article ItemGo behind the scenes of brain research at the 12th annual Brain School , article
Scientists will present their research through an interactive expo and panel discussion on focused ultrasound when the Fralin Biomedical Research Institute at VTC opens its doors for Brain School on March 10.
Date: Mar 05, 2025 - -
Article Item'Pocket Science' podcast: Why don't I slosh when I walk? , article
Human beings are mostly water, and about a fifth of that water is interstitial fluid, flowing in the spaces between our cells. Jenny Munson tells us how understanding that fluid flow can be harnessed to better treat cancer, Alzheimer's and other diseases.
Date: Feb 26, 2025 - -
Article ItemBuilding better biomaterials for cancer treatments , article
Slight changes in therapeutic nanoparticles and biomaterials may one day improve treatment outcomes for cancer patients.
Date: Feb 18, 2025 - -
Article ItemGraduate student’s research goal: Improve outcomes for brain cancer patients , article
A Jeanine L. Matte Fellowship will help advance Samantha Howerton’s doctoral research into personalized therapies for glioblastoma.
Date: Jan 29, 2025 - -
Article ItemVirginia Tech researchers ask how many attempts it takes to quit substance abuse , article
A Fralin Biomedical Research Institute analysis found that people trying to quit opioids and pain medication experience more relapses.
Date: Jan 24, 2025 - -
Article ItemFralin Biomedical Research Institute spinoff company translates science into peptide drugs targeting cancer stem cells , article
Bioentrepreneur Samy Lamouille recently joined a Johnson & Johnson life science and health care incubator, opening new avenues for networking and development.
Date: Nov 18, 2024 -
Page 1 of 12 | 116 Results
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect ItemNeuroscience News: Glioblastoma Drug Resistance Pathway Identified , redirect Date: May 20, 2024 -
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect ItemVirginia Business: Virginia Tech research institute receives $50M gift , redirect Date: Sep 12, 2023 -
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect ItemWSLS TV: Virginia Tech fraternity funds research fellowship , redirect Date: Feb 17, 2023 -
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect ItemMedi Magazine: Glioblastoma: new treatment strategy , redirect Date: Jan 16, 2022 -
-
Redirect ItemWN.com: Scientists develop new strategy for brain cancer treatment , redirect Date: Jan 15, 2022 -
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect ItemBioengineer: $100,000 to fund collaborative cancer research , redirect Date: Jan 14, 2021 -
-
Redirect ItemScienmag: $100,000 To Fund Collaborative Cancer Research , redirect Date: Jan 14, 2021 -
-
Redirect Item7th Space: $100,000 to fund collaborative cancer research , redirect Date: Jan 14, 2021 -
-
Redirect Item
-
Redirect Item
-
Redirect ItemSuper Human Radio: Study Shows Jet Lag Impairs The Immune System , redirect Date: Oct 30, 2020 -
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect ItemNeuroscience News: Jet Lag Conditions Impair Immune Response , redirect Date: Oct 14, 2020 -
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect ItemWFIR Radio: FBRI spinoff working on brain, breast cancer treatment , redirect Date: Jul 31, 2020 -
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect ItemThe Roanoke Times: Virginia Tech to launch cancer research initiative , redirect Date: Oct 15, 2019 -
-
Redirect ItemWVTF: Potential New Treatment for Deadliest Brain Diseases , redirect Date: Dec 05, 2018 -
-
Redirect Item
-
Redirect Item
-
Redirect ItemThe Roanoke Times: VTCRI offshot selected for inaugural RAMP cohort , redirect Date: May 29, 2017 -
-
Redirect Item
-
Redirect ItemWVTF: Glioblastoma canine clinical trials , redirect Date: Nov 16, 2015 -
-
Redirect Item
-
Home Item
Targeting Acquired Dependencies During Tumor Evolution , homeJune 6, 2025, 11:00 a.m. | Kris Wood, Ph.D., Associate Professor, Department of Pharmacology and Cancer Biology, Duke University School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Center – D.C.